查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404699

犬疫苗市场规模、份额、趋势分析报告：依疫苗类型、疾病类型、给药途径、免疫期、成分、地区、细分市场预测，2023-2030年

Dog Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type, By Disease Type, By Route Of Administration, By Duration Of Immunity, By Component, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 115 Pages | 商品交期: 2-10个工作天内

价格

犬疫苗市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球狗疫苗市场规模预计将达到26亿美元，预测期内复合年增长率为6.0%。

这种成长是由宠物人性化、千禧世代养宠物以及预防性医疗保健意识增强等趋势所推动的。根据勃林格殷格翰国际有限公司的数据，35% 的千禧世代和 32% 的婴儿潮世代拥有宠物。此外，宠物支出和保险的增加预计也将推动该市场的成长。根据 WorldAnimalFoundation.org 2023 年 2 月发表的报导，狗饲主比猫饲主多花费约 570 美元。

此外，宠物数量的增加、中国和印度等亚太新兴市场收入水准的提高以及随之而来的人们生活方式的变化预计将对狗疫苗行业的成长产生重大影响。例如，根据《经济时报》2023年7月发表的报导，印度人均收入预计将成长1.6倍，到2030年达到4,000美元。

犬疫苗市场报告亮点

  • 按疫苗类型划分，改良/减毒活病毒疫苗领域在 2022 年占据最大销售份额，为 52.4%，因为它有助于预防疾病并提供长期免疫力。
  • 按疾病类型划分，由于犬狂犬病的高盛行率和通用感染疾病，预计在预测期内，犬狂犬病将以 6.9% 的最快复合年增长率增长。
  • 从给药途径来看，注射剂占销售额的最大份额，到2022年将达到76.1%，因为注射剂非常方便且给药准确。
  • 依免疫期限划分，一年期给药型由于便利性高，2022年占51.2%的份额。
  • 以成分来看，组合疫苗占比最大，为 65.5%。由于其能够预防多种疾病，预计在预测期内将以 6.2% 的复合年增长率增长最快。
  • 由于大公司的存在以及对宠物预防性保健意识的提高，北美在 2022 年占据主导地位，占 38.8% 的份额。同时，由于中国和印度等新兴经济体开拓的商机，预计亚太地区在预测期内将以 7.0% 的复合年增长率成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章犬疫苗市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 狗狗疫苗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 犬用疫苗：疫苗种类估算及趋势分析

  • 狗狗疫苗市场：重点
  • 狗疫苗市场：2022 年和 2030 年趋势和市场占有率分析
  • 改良/减毒活病毒疫苗
    • 2018-2030 年变性/减毒活病毒疫苗市场估计与预测
  • 惰性（失活）
    • 惰性
  • 其他的
    • 2018-2030 年其他市场估计与预测

第五章犬疫苗：疾病类型估计与趋势分析

  • 狗狗疫苗市场：重点
  • 狗疫苗市场：2022 年和 2030 年趋势和市场占有率分析
  • 犬瘟热
    • 2018-2030 年犬瘟热市场估计与预测
  • 犬传染性呼吸道疾病综合体 (CIRDC)
    • 犬传染性呼吸道疾病复合体
  • 犬小病毒病/小病毒病
    • 2018-2030 年犬细小病毒病/细小病毒病市场估计与预测
  • 犬钩端螺旋体病
    • 2018-2030 年犬钩端螺旋体病市场估计与预测
  • 犬莱姆病
    • 2018-2030 年犬莱姆病市场估计与预测
  • 犬传染性肝炎
    • 2018-2030年犬传染性肝炎市场估计与预测
  • 狗狂犬病
    • 2018-2030 年犬狂犬病市场估计与预测
  • 其他疾病
    • 2018-2030 年其他疾病市场估计与预测

第六章 犬疫苗：给药途径的估算与趋势分析

  • 狗狗疫苗市场：重点
  • 狗疫苗市场：2022 年和 2030 年趋势和市场占有率分析
  • 可注射的
    • 2018-2030 年註射剂市场估计与预测
  • 鼻内
    • 2018-2030年鼻内市场估计与预测
  • 口服
    • 2018-2030 年口腔市场估计与预测

第七章 犬用疫苗：免疫估计与趋势分析

  • 狗狗疫苗市场：重点
  • 狗疫苗市场：2022 年和 2030 年趋势和市场占有率分析
  • 1年
    • 2018-2030 年 1 年市场估计与预测
  • 3年
    • 2018-2030 年 3 年市场估计与预测
  • 其他的
    • 2018-2030 年其他市场估计与预测

第 8 章 犬疫苗：成分估算与趋势分析

  • 狗狗疫苗市场：重点
  • 狗疫苗市场：2022 年和 2030 年趋势和市场占有率分析
  • 联合疫苗
    • 2018-2030 年联合疫苗市场估计与预测
  • 单一疫苗
    • 2018-2030 年单一疫苗市场估计与预测

第九章狗疫苗市场：区域估计和趋势分析

  • 区域展望
  • 按地区分類的狗疫苗市场：要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018-2030 年市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Bioveta, as
    • HESTER BIOSCIENCES LIMITED
    • Boehringer Ingelheim International GmbH
    • Brilliant Bio Pharma
    • Heska Corporation
    • Merck & Co., Inc.
    • Virbac
    • Zendal group
    • Elanco
    • Zoetis Services LLC
Product Code: GVR-4-68040-156-3

Dog Vaccine Market Growth & Trends:

The global dog vaccine market size is anticipated to reach USD 2.6 billion by 2030 and display a CAGR of 6.0% during the forecast period, according to a new report by Grand View Research, Inc. The growth can be attributed to the increasing trend of pet humanization, pet ownership among millennials, and rising consciousness regarding preventive healthcare. According to Boehringer Ingelheim International GmbH, 35% of millennials and 32% of baby boomers own a pet. In addition, the rise in pet spending and insurance is also expected to add to the growth of this market. According to an article published by WorldAnimalFoundation.org in February 2023, dog owners spent approximately USD 570 more than cat owners.

Moreover, the increasing pet population, rising income levels in emerging markets of Asia-Pacific, such as China and India, and consequent changes in the lifestyle of people are expected to impact the growth of the dog vaccine industry significantly. For instance, according to an article published by the Economic Times in July 2023, the per capita income in India is expected to increase by 1.6 times to reach USD 4000 by 2030.

Dog Vaccine Market Report Highlights:

  • Based on vaccine type, the modified/attenuated live vaccine segment accounted for the largest revenue share of 52.4% in 2022, as they help prevent disease and provide long-term immunity
  • Based on disease type, the canine rabies segment is expected to grow at the fastest CAGR of 6.9% over the forecast period due to the high prevalence of this disease and its zoonotic potential
  • Based on route of administration, the injectable segment accounted for the largest revenue share of 76.1% in 2022, owing to their convenience and ability to administer accurate dosage amounts
  • Based on duration of immunity, the 1-year segment dominated the market with a share of 51.2% in 2022 owing to their convenience
  • Based on component, the combined vaccines segment accounted for the largest market share of 65.5%. It is expected to grow at the fastest CAGR of 6.2% over the forecast period due to its ability to protect against more than one disease
  • North America dominated with a share of 38.8% in 2022, owing to the presence of major players and increasing awareness regarding preventive healthcare for pets. On the other hand, Asia Pacific is anticipated to grow at the fastest CAGR of 7.0% over the forecast period due to untapped opportunities in the emerging economies of China and India

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Vaccine type
    • 1.1.2. Disease type
    • 1.1.3. Route of administration
    • 1.1.4. Duration of immunity
    • 1.1.5. Component
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Vaccine type outlook
    • 2.2.2. Disease type outlook
    • 2.2.3. Route of administration outlook
    • 2.2.4. Duration of immunity outlook
    • 2.2.5. Component outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Dog Vaccine Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Dog Vaccine Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Dog Vaccine: Vaccine Type Estimates & Trend Analysis

  • 4.1. Dog Vaccine Market: Key Takeaways
  • 4.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Modified/Attenuated Live
    • 4.3.1. Modified/ attenuated live market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Inactivated (Killed)
    • 4.4.1. Inactivated (Killed) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Dog Vaccine: Disease Type Estimates & Trend Analysis

  • 5.1. Dog Vaccine Market: Key Takeaways
  • 5.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Canine Distemper
    • 5.3.1. Canine distemper market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Canine Infectious Respiratory Disease Complex (CIRDC)
    • 5.4.1. Canine infectious respiratory disease complex (CIRDC) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Canine Parvovirosis/ Parvovirus Disease
    • 5.5.1. Canine parvovirosis/ parvovirus disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Canine Leptospirosis
    • 5.6.1. Canine leptospirosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Canine Lyme Disease
    • 5.7.1. Canine lyme disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Infectious Canine Hepatitis
    • 5.8.1. Infectious canine hepatitis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Canine Rabies
    • 5.9.1. Canine distemper market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. Other Diseases
    • 5.10.1. Other diseases market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Dog Vaccine: Route of Administration Estimates & Trend Analysis

  • 6.1. Dog Vaccine Market: Key Takeaways
  • 6.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Injectable
    • 6.3.1. Injectable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Intranasal
    • 6.4.1. Intranasal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Oral
    • 6.5.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Dog Vaccine: Duration of Immunity Estimates & Trend Analysis

  • 7.1. Dog Vaccine Market: Key Takeaways
  • 7.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. 1 Year
    • 7.3.1. 1-year market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. 3 Year
    • 7.4.1. 3-year market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Others
    • 7.5.1. others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Dog Vaccine: Component Estimates & Trend Analysis

  • 8.1. Dog Vaccine Market: Key Takeaways
  • 8.2. Dog Vaccine Market: Movement & Market Share Analysis, 2022 & 2030
  • 8.3. Combined Vaccines
    • 8.3.1. Combined vaccines market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.4. Mono Vaccines
    • 8.4.1. Mono vaccines market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Dog Vaccine Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Outlook
  • 9.2. Dog Vaccine Market by Region: Key Takeaways
  • 9.3. North America
    • 9.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.4. Europe
    • 9.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework/reimbursement structure
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework/reimbursement structure
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework/reimbursement structure
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework/reimbursement structure
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework/reimbursement structure
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework/reimbursement structure
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework/reimbursement structure
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key country dynamics
      • 9.4.9.2. Regulatory framework/reimbursement structure
      • 9.4.9.3. Competitive scenario
      • 9.4.9.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/reimbursement structure
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.5. Thailand
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework/reimbursement structure
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.5.6. South Korea
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework/reimbursement structure
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.2. Mexico
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Market Participant Categorization
    • 10.2.1. Bioveta, a.s.
      • 10.2.1.1. Company overview
      • 10.2.1.2. Financial performance
      • 10.2.1.3. Product benchmarking
      • 10.2.1.4. Strategic initiatives
    • 10.2.2. HESTER BIOSCIENCES LIMITED
      • 10.2.2.1. Company overview
      • 10.2.2.2. Financial performance
      • 10.2.2.3. Product benchmarking
      • 10.2.2.4. Strategic initiatives
    • 10.2.3. Boehringer Ingelheim International GmbH
      • 10.2.3.1. Company overview
      • 10.2.3.2. Financial performance
      • 10.2.3.3. Product benchmarking
      • 10.2.3.4. Strategic initiatives
    • 10.2.4. Brilliant Bio Pharma
      • 10.2.4.1. Company overview
      • 10.2.4.2. Financial performance
      • 10.2.4.3. Product benchmarking
      • 10.2.4.4. Strategic initiatives
    • 10.2.5. Heska Corporation
      • 10.2.5.1. Company overview
      • 10.2.5.2. Financial performance
      • 10.2.5.3. Product benchmarking
      • 10.2.5.4. Strategic initiatives
    • 10.2.6. Merck & Co., Inc.
      • 10.2.6.1. Company overview
      • 10.2.6.2. Financial performance
      • 10.2.6.3. Product benchmarking
      • 10.2.6.4. Strategic initiatives
    • 10.2.7. Virbac
      • 10.2.7.1. Company overview
      • 10.2.7.2. Financial performance
      • 10.2.7.3. Product benchmarking
      • 10.2.7.4. Strategic initiatives
    • 10.2.8. Zendal group
      • 10.2.8.1. Company overview
      • 10.2.8.2. Financial performance
      • 10.2.8.3. Product benchmarking
      • 10.2.8.4. Strategic initiatives
    • 10.2.9. Elanco
      • 10.2.9.1. Company overview
      • 10.2.9.2. Financial performance
      • 10.2.9.3. Product benchmarking
      • 10.2.9.4. Strategic initiatives
    • 10.2.10. Zoetis Services LLC
      • 10.2.10.1. Company overview
      • 10.2.10.2. Financial performance
      • 10.2.10.3. Product benchmarking
      • 10.2.10.4. Strategic initiatives

List of Tables

  • 1. List of abbreviations
  • 2. North America dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 3. North America dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 4. North America dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 5. North America dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 6. North America dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 7. North America dog vaccine market, by region, 2018 - 2030 (USD Million)
  • 8. U.S. dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 9. U.S. dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 10. U.S. dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 11. U.S. dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 12. U.S. dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 13. Canada dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 14. Canada dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 15. Canada dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 16. Canada dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 17. Canada dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 18. Europe dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 19. Europe dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 20. Europe dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 21. Europe dog vaccine market, by duration of immunity type, 2018 - 2030 (USD Million)
  • 22. Europe dog vaccine market, by component type, 2018 - 2030 (USD Million)
  • 23. Europe dog vaccine market, by region, 2018 - 2030 (USD Million)
  • 24. UK dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 25. UK dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 26. UK dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 27. UK dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 28. UK dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 29. Germany dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 30. Germany dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 31. Germany dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 32. Germany dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 33. Germany Dog Vaccine market, by component, 2018 - 2030 (USD Million)
  • 34. France dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 35. France dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 36. France dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 37. France dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 38. Italy dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 39. Italy dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 40. Italy dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 41. Italy dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 42. Italy dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 43. Spain dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 44. Spain dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 45. Spain dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 46. Spain dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 47. Spain dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 48. Sweden dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 49. Sweden dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 50. Sweden dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 51. Sweden dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 52. Sweden dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 53. Norway dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 54. Norway dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 55. Norway dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 56. Norway pain dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 57. Norway dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 58. Denmark dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 59. Denmark dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 60. Denmark dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 61. Denmark dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 62. Denmark dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 63. Asia-Pacific dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 64. Asia-Pacific dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 65. Asia-Pacific dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 66. Asia-Pacific dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 67. Asia-Pacific dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 68. Asia pacific dog vaccine market, by region, 2018 - 2030 (USD Million)
  • 69. Japan dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 70. Japan dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 71. Japan dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 72. Japan dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 73. Japan dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 74. China dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 75. China dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 76. China dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 77. China dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 78. China dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 79. India dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 80. India dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 81. India dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 82. India dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 83. India dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 84. Australia dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 85. Australia dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 86. Australia dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 87. Australia dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 88. Australia dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 89. Thailand dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 90. Thailand dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 91. Thailand dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 92. Thailand dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 93. Thailand dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 94. South Korea dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 95. South Korea dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 96. South Korea dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 97. South Korea dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 98. South Korea dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 99. Latin America dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 100. Latin America dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 101. Latin America dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 102. Latin America dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 103. Latin America dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 104. Latin America Dog Vaccine market, by region, 2018 - 2030 (USD Million)
  • 105. Brazil dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 106. Brazil dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 107. Brazil dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 108. Brazil dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 109. Brazil dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 110. Mexico dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 111. Mexico dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 112. Mexico dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 113. Mexico dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 114. Mexico dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 115. Argentina dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 116. Argentina dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 117. Argentina dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 118. Argentina dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 119. Argentina dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 120. Middle East and Africa dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 121. Middle East and Africa dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 122. Middle East and Africa dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 123. Middle East and Africa dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 124. Middle East and Africa dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 125. Middle East and Africa Dog Vaccine market, by region, 2018 - 2030 (USD Million)
  • 126. South Africa dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 127. South Africa dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 128. South Africa dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 129. South Africa dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 130. South Africa dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 131. Saudi Arabia dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 132. Saudi Arabia dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 133. Saudi Arabia dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 134. Saudi Arabia dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 135. Saudi Arabia dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 136. UAE dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 137. UAE dog vaccine market, by disease type, 2018 - 2030 (USD Million)
  • 138. UAE dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 139. UAE dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 140. UAE dog vaccine market, by component, 2018 - 2030 (USD Million)
  • 141. Kuwait dog vaccine market, by vaccine type, 2018 - 2030 (USD Million)
  • 142. Kuwait dog vaccine market, by disease type, 2018 - 2030 (USD Million)]
  • 143. Kuwait dog vaccine market, by route of administration, 2018 - 2030 (USD Million)
  • 144. Kuwait dog vaccine market, by duration of immunity, 2018 - 2030 (USD Million)
  • 145. Kuwait dog vaccine market, by component, 2018 - 2030 (USD Million)

List of Figure

1. Market research process

2. Data triangulation techniques

3. Primary research pattern

4. Market research approaches

5. QFD modeling for market share assessment

6. Market formulation & validation

7. Dog Vaccines: Market outlook

8. Dog Vaccines: Competitive insights

9. Parent market outlook

10. Related/ancillary market outlook

11. Penetration and growth prospect mapping

12. Industry value chain analysis

13. Dog vaccine market driver impact

14. Dog vaccine market restraint impact

15. Dog vaccine market strategic initiatives analysis

16. Dog vaccine market: Vaccine type movement analysis

17. Dog vaccine market: Vaccine type outlook and key takeaways

18. Modified/ attenuated live market estimates and forecasts, 2018 - 2030

19. Inactivated (Killed) market estimates and forecasts, 2018 - 2030

20. Others market estimates and forecasts, 2018 - 2030

21. Dog vaccine market: Disease type movement analysis

22. Dog vaccine market: Disease type outlook and key takeaways

23. Canine distemper market estimates and forecasts, 2018 - 2030

24. Canine infectious respiratory disease complex (CIRDC)market estimates and forecasts, 2018 - 2030

25. Canine parvovirosis/ parvovirus disease market estimates and forecasts, 2018 - 2030

26. Canine Lyme disease market estimates and forecasts, 2018 - 2030

27. Infectious canine hepatitis market estimates and forecasts, 2018 - 2030

28. Canine rabies market estimates and forecasts, 2018 - 2030

29. Other diseases market estimates and forecasts, 2018 - 2030

30. Dog Vaccine market: Route of administration movement analysis

31. Dog Vaccine market: Route of administration outlook and key takeaways

32. Injectable market estimates and forecasts, 2018 - 2030

33. Intranasal market estimates and forecasts, 2018 - 2030

34. Oral market estimates and forecasts, 2018 - 2030

35. Dog Vaccine market: Duration of immunity movement analysis

36. Dog Vaccine market: Duration of immunity outlook and key takeaways

37. 1 year market estimates and forecasts, 2018 - 2030

38. 3-year market estimates and forecasts, 2018 - 2030

39. others market estimates and forecasts, 2018 - 2030

40. Dog Vaccine market: Component movement analysis

41. Dog Vaccine market: Component of immunity outlook and key takeaways

42. Combined vaccines market estimates and forecasts, 2018 - 2030

43. Mono vaccines market estimates and forecasts, 2018 - 2030

44. Global dog vaccine market: Regional movement analysis

45. Global dog vaccine market: Regional outlook and key takeaways

46. North America market estimates and forecasts, 2018 - 2030

47. U.S. market estimates and forecasts, 2018 - 2030

48. Canada market estimates and forecasts, 2018 - 2030

49. Europe market estimates and forecasts, 2018 - 2030

50. UK market estimates and forecasts, 2018 - 2030

51. Germany market estimates and forecasts, 2018 - 2030

52. France market estimates and forecasts, 2018 - 2030

53. Italy market estimates and forecasts, 2018 - 2030

54. Spain market estimates and forecasts, 2018 - 2030

55. Denmark market estimates and forecasts, 2018 - 2030

56. Sweden market estimates and forecasts, 2018 - 2030

57. Norway market estimates and forecasts, 2018 - 2030

58. Asia Pacific market estimates and forecasts, 2018 - 2030

59. Japan market estimates and forecasts, 2018 - 2030

60. China market estimates and forecasts, 2018 - 2030

61. India market estimates and forecasts, 2018 - 2030

62. Australia market estimates and forecasts, 2018 - 2030

63. Thailand market estimates and forecasts, 2018 - 2030

64. South Korea market estimates and forecasts, 2018 - 2030

65. Latin America market estimates and forecasts, 2018 - 2030

66. Brazil market estimates and forecasts, 2018 - 2030

67. Mexico market estimates and forecasts, 2018 - 2030

68. Argentina market estimates and forecasts, 2018 - 2030

69. Middle East and Africa. market estimates and forecasts, 2018 - 2030

70. Saudi Arabia market estimates and forecasts, 2018 - 2030

71. South Africa market estimates and forecasts, 2018 - 2030

72. UAE market estimates and forecasts, 2018 - 2030

73. Kuwait market estimates and forecasts, 2018 - 2030